消化道肿瘤肝转移瘤介入治疗的临床疗效观察

Clinical efficacy of interventional therapy for hepatic metastases of digestive tract tumors

目的:探讨介入治疗消化道肿瘤肝转移瘤的效果。方法:收治消化道肿瘤肝转移瘤患者66例,评估、分析临床治疗效果。结果:患者平均生存期(18.9±3.1)个月,1、3、5年的生存率分别为83.3%(55/66)、39.4%(26/66)、12.1%(8/66)。结论:介入治疗无法根治消化道肿瘤肝转移瘤,只能在一定程度上延长患者的生存期。若原发病灶位于胰腺,预后较差,患者生存期较短;若原发肿瘤已经切除,或原发肿瘤为富血供肿瘤,则预后较好,患者生存期相对更长。

Objective:To investigate the effect of interventional therapy on hepatic metastases of digestive tract tumors.Methods:66 patients with hepatic metastases from digestive tract tumor were selected,then their clinical effect was evaluated and analyzed.Results:The average survival time of the patients was(18.9±3.1) months,the survival rate at 1,3,5 years were 83.3%(55/66),39.4%(26/66),12.1%(8/66).Conclusion:Interventional therapy can not cure the liver metastases of digestive tract tumor.It can only extend the survival time of the patients at a certain extent.If the primary lesion is located in the stomach and pancreas,the prognosis is poor,and the survival time of the patients is relatively short.If the primary tumor has been resected or the primary tumor is a rich blood donor tumor,the prognosis is better,and the survival time of the patient is longer.